Systematic Evaluation and Validation of Benzodiazepines Confirmation Assay Using LC-MS-MS

Area of Science:

• Forensic Chemistry
• Analytical Chemistry

Background:

• Benzodiazepines are widely prescribed for anxiety and sleep disorders.
• Misuse of benzodiazepines is linked to criminal activities, necessitating reliable detection methods.
• Clinical laboratories require robust assays for confirmatory benzodiazepine testing.

Purpose of the Study:

• To systematically evaluate four beta-glucuronidase enzymes for hydrolysis efficiency.
• To assess matrix effects and extraction recoveries using three protein precipitation plates.
• To develop and validate a sensitive method for benzodiazepine monitoring in urine.

Main Methods:

• Hydrolysis efficiency of four beta-glucuronidase enzymes was compared.
• Protein precipitation plates were evaluated for matrix effects and extraction recovery.
• Analytes were separated on a superficially porous particle column and detected using electrospray ionization-tandem mass spectrometry.
• Method validation included accuracy, precision, detection limits, and quantification limits.

Main Results:

• Recombinant IMCSzyme demonstrated superior hydrolysis efficiency compared to other enzymes.
• The Supelco protein precipitation plate exhibited lower ion suppression and better recovery.
• The developed method achieved rapid separation (4.5 min) and sensitive detection of benzodiazepines.
• Analysis of 60 opioid-positive urine samples revealed a high incidence of benzodiazepines.

Conclusions:

• The recombinant IMCSzyme and Supelco plate offer an efficient approach for benzodiazepine hydrolysis and extraction.
• The validated ultra-high-performance liquid chromatography-tandem mass spectrometry method is robust for routine urine monitoring.
• This technique effectively detects numerous benzodiazepines, addressing the need for improved clinical laboratory assays.